Background: Mikulicz's disease (MD) has been considered as one manifestation of Sjögren's syndrome (SS). Recently, MD has also been considered as an IgG4-related disorder.
Objective: To determine the differences between IgG4-related disorders including MD and SS. Patients and Methods: We investigated patients with MD and IgG4-related disorders registered from all over Japan, and set up provisional criteria for the new clinical entity: IgG4-positive multi-organ lymphoproliferative syndrome (IgG4+MOLPS). The preliminary diagnostic criteria include elevated serum IgG4 (>135 mg/dl) and infiltration of IgG4+ plasma cells in the tissue (IgG4+/IgG+ plasma cells >50%) with fibrosis or sclerosis. We compared clinical features, laboratory data and pathologies of 64 patients with IgG4+MOLPS and 31 patients with typical SS.
Results: The incidences of xerostomia, xerophthalmia and arthralgia, rheumatoid factor and anti-nuclear, anti-SS-A/Ro and anti-SS-B/La antibodies were significantly lower in IgG4+MOLPS than typical SS patients. Allergic rhinitis and autoimmune pancreatitis were significantly more frequent and total IgG, IgG2, IgG4 and IgE were significantly elevated in IgG4+MOLPS. Histological specimen from patients with IgG4+MOLPS revealed marked IgG4+ plasma cell infiltration. Many patients with IgG4+MOLPS showed lymphocytic follicle formation, but lymphoepithelial lesions were rare. Few IgG4+ cells were seen in the tissue of typical SS. Thirty-eight patients with IgG4+MOLPS treated with glucocorticoids showed marked clinical improvements.
Conclusion: Despite similarities in the involved organs, there are marked clinical and pathological differences between IgG4+MOLPS and SS. Based on the clinical features and good response to glucocorticoid, we propose a new clinical entity: IgG4+MOLPS.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.